Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study

Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study

Abstract Introduction This retrospective database study explored treatment patterns and potential off-label prescribing among patients newly prescribed fluticasone furoate/vilanterol (FF/VI) in a UK primary care setting. Methods In Europe, FF/VI is approved in two strengths: 100/25 µg for adults wit...

Full description

Bibliographic Details
Main Authors: Daniel Dedman, Sonia J. Coton, Rebecca E. Ghosh, Wilhelmine Meeraus, Courtney Crim, Catherine Harvey, Justyna Amelio, Sarah H. Landis
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-04-01
Series:Pulmonary Therapy
Subjects:
Asthma
Chronic obstructive pulmonary disease (COPD)
Fluticasone furoate/vilanterol (FF/VI)
Primary care
Online Access:http://link.springer.com/article/10.1007/s41030-019-0092-z

Internet

http://link.springer.com/article/10.1007/s41030-019-0092-z

Similar Items